Andean Precious Metals (CVE:APM) Stock Price Up 7.5% - Should You Buy?

Shares of Andean Precious Metals Corp. (CVE:APM - Get Free Report) traded up 7.5% on Thursday . The company traded as high as C$1.29 and last traded at C$1.29. 225,691 shares traded hands during mid-day trading, an increase of 41% from the average session volume of 159,585 shares. The stock had previously closed at C$1.20.

Analysts Set New Price Targets

Separately, Desjardins raised shares of Andean Precious Metals to a "moderate buy" rating in a research note on Thursday, October 31st.

Andean Precious Metals Price Performance

The firm's fifty day simple moving average is C$1.32 and its 200 day simple moving average is C$1.26. The company has a market capitalization of C$192.67 million, a PE ratio of 3.39 and a beta of 1.22.

Insider Activity at Andean Precious Metals

In other news, Senior Officer Juan Carlos Sandoval Amare purchased 31,300 shares of the company's stock in a transaction that occurred on Friday, January 3rd. The stock was purchased at an average cost of C$1.21 per share, for a total transaction of C$37,860.48. 69.37% of the stock is owned by company insiders.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.